Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
2.
Altern Ther Health Med ; 23(4): 56-61, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28646815

ABSTRACT

Context • Small intestinal bacterial overgrowth (SIBO) is commonly defined as an increased number of bacteria and/or an abnormal type of bacteria in the small intestine. Conventional treatment for SIBO is typically focused on antibiotics to eradicate the bacterial overgrowth. Numerous studies have demonstrated the antimicrobial activity of herbs, and a diet low in fermentable oligo-, di-, and monosaccharides and polyols (FODMAPs) has been shown to enhance antibiotic therapy. Objective • The current case study intended to evaluate the benefits of an alternative, multifaceted approach-including botanical and homeopathic therapies in conjunction with a low-FODMAP diet-in the treatment of SIBO and its associated symptoms. Design • The research team performed a case study. Setting • The study was conducted at SCNM Medical Center (Tempe, AZ, USA). Participant • The participant was a female patient at the SCNM Medical Center with chronic, daily, severe abdominal bloating and pain that particularly worsened after meals and by the end of the day. The patient also had a significant history of chronic constipation that had begun approximately 10 y prior to her experiencing the daily abdominal pain. Intervention • Based on a lactulose breath test for hydrogen and methane, the research team diagnosed the patient with a case of mild SIBO. The treatment approach was multifaceted, involving a low-FODMAP diet, antimicrobial botanical therapy, and homeopathic medicine. Results • The patient's abdominal pain and bloating resolved with the treatment of the SIBO, although her underlying constipation, which was likely associated with other factors, remained. Conclusions • This case study supports an alternative, multifaceted approach to the treatment of SIBO and commonly associated symptoms.


Subject(s)
Blind Loop Syndrome/therapy , Diet Therapy , Homeopathy , Phytotherapy , Probiotics/therapeutic use , Abdominal Pain/etiology , Adult , Blind Loop Syndrome/complications , Blind Loop Syndrome/diagnosis , Breath Tests , Chronic Disease , Citrullus colocynthis , Constipation/complications , Disaccharides , Female , Fermentation , Humans , Monosaccharides , Oligosaccharides , Polymers
6.
Arq Gastroenterol ; 58(1): 120-126, 2021.
Article in English | MEDLINE | ID: mdl-33909790

ABSTRACT

BACKGROUND: Irritable bowel syndrome (IBS) is a complex gastrointestinal disorder, whose understanding is relatively uncertain, and the treatment guidance decision still represents a challenge. OBJECTIVE: To identify and critically appraise systematic reviews (SRs) published in the Cochrane Database of SRs (CDSR) on the effects of interventions (pharmacological and non-pharmacological) for the treatment of IBS. METHODS: The search was conducted at the Cochrane Library in May 2020. The methodological quality of the SRs was evaluated by the AMSTAR-2 tool. RESULTS: Eight SRs with moderate to high quality were included, which addressed the treatments: (a) pharmacological: volume agents, antispasmodics, antidepressants and tegaserod; and (b) non-pharmacological: homeopathy, acupuncture, phytotherapy, biofeedback, psychological interventions and hypnotherapy. The results were favorable to antispasmodic drugs and antidepressants regarding the improvement of clinical symptoms. There was no difference between volume agents or tegaserod when compared to placebo. Acupuncture and homeopathy showed a little improvement in symptoms compared to placebo, but the certainty of this evidence was considered low to very low. Psychological interventions seem to improve the overall assessment of the patient and relief symptoms such as abdominal pain. However, there was no long-term follow-up of these patients. The results of the other treatments were considered uncertain due to the high risk of bias. CONCLUSION: Considering the low quality of the studies included in the SRs, pharmacological treatment with antispasmodics and antidepressants seems to be beneficial for patients with IBS. Among non-pharmacological interventions, psychological interventions seem to be beneficial. However, further clinical trials are recommended with greater methodological rigor to prove these findings.


Subject(s)
Irritable Bowel Syndrome , Abdominal Pain , Humans , Irritable Bowel Syndrome/drug therapy , Phytotherapy
7.
Medicine (Baltimore) ; 98(35): e16895, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31464920

ABSTRACT

RATIONALE: Methotrexate (MTX) is an antimetabolite of folic acid, which is used for management of ectopic pregnancy. MTX-related toxicity may include cutaneous mucosal damage, bone marrow suppression, gastrointestinal disorders (gastritis, diarrhea, hematitis), liver and kidney function damage, pulmonary toxicity, cardiac toxicity, and nerve toxicity. However, it is not usual for vulvar edema induced by low-dose methotrexate. PATIENT CONCERNS: In this case report, we described a patient with severe vulvar edema and oral cavity ulceration and scalp ulceration induced by low-dose MTX treatment for ectopic pregnancy. Her presenting complaints were pain in the vulva, oral cavity, and scalp. DIAGNOSES: The patient was diagnosed based on clinical findings for MTX toxic reactions. INTERVENTIONS: Vulva was disinfectioned with iodide and Kangfuxin solution, her mouth was rinsed with mouthwash. Three compound glycyrrhizin tablets were orally administered (3 times/day). After 10 days, the broken skin and mucous membrane healed. OUTCOMES: The vulvar edema and oral cavity ulceration and scalp ulceration healed. LESSONS: Our study demonstrated that even low-dose MTX can be induced skin and mucosal injury, patients and doctors should timely detection of drug toxicity reactions, immediately rescue, prompt discontinuation of medication, and symptomatic treatment to avoid accidental occurrence.


Subject(s)
Methotrexate/administration & dosage , Metronidazole/administration & dosage , Pregnancy, Ectopic/drug therapy , Trichomonas Vaginitis/drug therapy , Vulvar Diseases/chemically induced , Abdominal Pain/etiology , Administration, Oral , Adult , China , Female , Glycyrrhizic Acid/administration & dosage , Glycyrrhizic Acid/therapeutic use , Humans , Injections, Intramuscular , Materia Medica/administration & dosage , Materia Medica/therapeutic use , Methotrexate/adverse effects , Metronidazole/therapeutic use , Pregnancy , Pregnancy, Ectopic/diagnosis , Treatment Outcome , Uterine Hemorrhage/etiology , Vulvar Diseases/drug therapy
9.
Arch Iran Med ; 9(1): 72-5, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16649384

ABSTRACT

Although the incidence of occupational and adult lead poisoning has declined, the problem still exists. We encountered three patients with lead poisoning in Iran, all of whom associated with presented with diffuse abdominal pain, which was at times colicky in nature, anemia, constipation, nausea, vomiting, and slightly abnormal liver biochemistries. A history of opium ingestion was present in each of these patients. None of the patients reported known occupational exposure to toxins. Diagnoses of lead poisoning were confirmed through the detection of elevated blood lead levels. The cause of lead poisoning was attributed to the ingestion of contaminated opium. Opium adulterated with lead had not been previously recognized as a source of lead poisoning in Iran. It is, therefore, pointed out that lead poisoning should be considered as a differential diagnosis for acute abdominal colic of unclear cause in patients with opium addiction.


Subject(s)
Abdominal Pain/etiology , Drug Contamination , Lead Poisoning/blood , Opium/adverse effects , Adult , Chelating Agents/administration & dosage , Edetic Acid/administration & dosage , Humans , Iran/epidemiology , Male , Middle Aged , Opioid-Related Disorders/blood , Opium/blood , Self Medication
10.
Arq. gastroenterol ; 58(1): 120-126, Jan.-Mar. 2021. tab, graf
Article in English | LILACS | ID: biblio-1248995

ABSTRACT

ABSTRACT BACKGROUND: Irritable bowel syndrome (IBS) is a complex gastrointestinal disorder, whose understanding is relatively uncertain, and the treatment guidance decision still represents a challenge. OBJECTIVE: To identify and critically appraise systematic reviews (SRs) published in the Cochrane Database of SRs (CDSR) on the effects of interventions (pharmacological and non-pharmacological) for the treatment of IBS. METHODS: The search was conducted at the Cochrane Library in May 2020. The methodological quality of the SRs was evaluated by the AMSTAR-2 tool. RESULTS: Eight SRs with moderate to high quality were included, which addressed the treatments: (a) pharmacological: volume agents, antispasmodics, antidepressants and tegaserod; and (b) non-pharmacological: homeopathy, acupuncture, phytotherapy, biofeedback, psychological interventions and hypnotherapy. The results were favorable to antispasmodic drugs and antidepressants regarding the improvement of clinical symptoms. There was no difference between volume agents or tegaserod when compared to placebo. Acupuncture and homeopathy showed a little improvement in symptoms compared to placebo, but the certainty of this evidence was considered low to very low. Psychological interventions seem to improve the overall assessment of the patient and relief symptoms such as abdominal pain. However, there was no long-term follow-up of these patients. The results of the other treatments were considered uncertain due to the high risk of bias. CONCLUSION: Considering the low quality of the studies included in the SRs, pharmacological treatment with antispasmodics and antidepressants seems to be beneficial for patients with IBS. Among non-pharmacological interventions, psychological interventions seem to be beneficial. However, further clinical trials are recommended with greater methodological rigor to prove these findings.


RESUMO CONTEXTO: A síndrome do intestino irritável (SII) é um distúrbio gastrointestinal complexo, cujo entendimento é relativamente incerto e a decisão de orientação do tratamento ainda representa um desafio. OBJETIVO: Identificar e avaliar criticamente as revisões sistemáticas (RSs) publicadas na base de dados de RSs Cochrane (CDSR) sobre os efeitos das intervenções (farmacológicas e não farmacológicas) para o tratamento da SII. MÉTODOS: A busca foi realizada na Biblioteca Cochrane em maio de 2020. A qualidade metodológica das RSs foi avaliada pela ferramenta AMSTAR-2. RESULTADOS: Foram incluídas oito RSs com qualidade moderada a alta, as quais abordaram os tratamentos: (a) farmacológico - agentes de volume, antiespasmódicos, antidepressivos e o tegaserod; e (b) não farmacológico - homeopatia, acupuntura, fitoterapia, biofeedback, intervenções psicológicas e hipnoterapia. Os resultados foram favoráveis aos medicamentos antiespasmódicos e antidepressivos em relação à melhora dos sintomas clínicos. Não houve diferença entre os agentes de volume ou tegaserod quando comparados ao placebo. Acupuntura e homeopatia apresentaram pequena melhora dos sintomas em comparação ao placebo, porém a qualidade da evidência foi considerada baixa a muito baixa. As intervenções psicológicas parecem melhorar a avaliação global do paciente e alívio de sintomas como dor abdominal. Contudo, não houve acompanhamento desses pacientes a longo prazo. Os resultados dos demais tratamentos foram considerados incertos devido ao alto risco de viés. CONCLUSÃO: Considerando a baixa qualidade dos estudos incluídos nas RSs, o tratamento farmacológico com antiespasmódicos e antidepressivos parece ser benéfico para os pacientes com SII. Entre os não-farmacológicos, as intervenções psicológicas parecem obter benefícios. Entretanto, novos ensaios clínicos são recomendados com maior rigor metodológico para comprovar estes achados.


Subject(s)
Humans , Irritable Bowel Syndrome/drug therapy , Abdominal Pain , Phytotherapy
11.
urol. colomb. (Bogotá. En línea) ; 29(3): 176-177, 2020. tab
Article in Spanish | LILACS, COLNAL | ID: biblio-1411024

ABSTRACT

En el volumen 28, número 1 del 2019 de la revista Urología Colombiana se publicó el artículo titulado "Dolor abdominal agudo secundario a la rotura de tumor de Wilms: reporte de caso", el mismo que haciendo una búsqueda en Google presenta similar contenido al publicado en otra revista. En la [Tabla 1] se describen las similitudes en el paciente encontradas en los resúmenes de las dos revistas.


In volume 28, number 1 of 2019 of the journal Urología Colombiana, the article entitled "Acute abdominal pain secondary to Wilms tumor rupture: case report" was published, the same one that doing a Google search presents similar content to the one published in another journal. Table 1] describes the similarities in the patient found in the abstracts of the two journals.


Subject(s)
Humans , Periodicals as Topic , Research Report , Abdominal Pain , Similar , Wilms Tumor
12.
Bone Marrow Transplant ; 19(5): 525-6, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9052925

ABSTRACT

A patient developing acute pancreatitis with pseudocyst formation after an uncomplicated bone marrow harvest is reported. The diagnosis was confirmed by elevated serum amylase and lipase, and by CT scan. We suggest that the pancreatitis may have been precipitated by spasm of the sphincter of Oddi secondary to opiates administered as premedication and for pain relief.


Subject(s)
Analgesics, Opioid/adverse effects , Bone Marrow , Codeine/adverse effects , Common Bile Duct Diseases/chemically induced , Opium/adverse effects , Pancreatic Pseudocyst/etiology , Pancreatitis/etiology , Preanesthetic Medication/adverse effects , Tissue Donors , Abdominal Pain/chemically induced , Acute Disease , Amylases/blood , Analgesics, Opioid/pharmacology , Biomarkers , Bone Marrow Transplantation , Codeine/pharmacology , Humans , Lipase/blood , Male , Middle Aged , Opium/pharmacology , Pancreatic Pseudocyst/blood , Pancreatitis/blood , Spasm/chemically induced , Sphincter of Oddi/drug effects
13.
BMJ ; 305(6853): 554-6, 1992 Sep 05.
Article in English | MEDLINE | ID: mdl-1393034

ABSTRACT

OBJECTIVES: (a) to determine the efficacy of papaveretum in treating pain when administered early to patients presenting with acute abdominal pain and (b) to assess its effect on subsequent diagnosis and management. DESIGN: Prospective, randomised, placebo controlled study. SETTING: Walsgrave Hospital, Coventry. SUBJECTS: 100 consecutive patients with clinically significant abdominal pain who were admitted as emergencies to a surgical firm. INTERVENTIONS: Intramuscular injection of up to 20 mg papaveretum or an equivalent volume of saline. OUTCOME MEASURES: Pain and tenderness scores, assessment of patient comfort, accuracy of diagnosis, and management decisions. RESULTS: Median pain and tenderness scores were lower after papaveretum (pain score 8.3 in control group and 3.1 in treatment group, p < 0.0001; tenderness score 8.1 in control group and 5.1 in treatment group, p < 0.0001). Forty eight patients were deemed to be comfortable after papaveretum compared with nine after saline. Incorrect diagnoses and management decisions applied to two patients after papaveretum compared with nine patients after saline. CONCLUSION: Early administration of opiate analgesia to patients with acute abdominal pain can greatly reduce their pain. This does not interfere with diagnosis, which may even be facilitated despite a reduction in the severity of physical signs. These patients should not be denied effective treatment.


Subject(s)
Abdominal Pain/drug therapy , Opium/therapeutic use , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Acute Disease , Diagnostic Errors , Emergencies , Female , Humans , Male , Middle Aged , Pain Measurement , Prospective Studies , Safety , Time Factors
15.
J Gastrointestin Liver Dis ; 18(2): 225-7, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19565057

ABSTRACT

We describe the case of a 40-year old Iranian man who was admitted to our hospital with severe abdominal pain, abnormal liver function tests and normocytic anemia. Suffering from multiple sclerosis, he was a regular user of opium for pain relief. Basophilic stippling of erythrocytes pointed towards the diagnosis of lead intoxication, the most likely source being contaminated Iranian opium. Serum lead and zinc protoporphyrin levels were strongly elevated. To assess the hepatotoxic effects of lead poisoning a liver biopsy was performed. Pathomorphologic findings of hepatotoxicity, rarely reported in humans, included active hepatitis together with extensive microvesicular and macrovesicular steatosis, hemosiderosis and cholestasis, and a lymphocytic cholangitis. Whilst treated with chelating therapy, liver enzymes returned to normal, suggesting reversibility of the histological findings.


Subject(s)
Lead Poisoning/pathology , Liver/pathology , Opioid-Related Disorders , Opium , Abdominal Pain/etiology , Adult , Anemia/etiology , Anemia/pathology , Chelating Agents/therapeutic use , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/pathology , Cholangitis/etiology , Cholangitis/pathology , Drug Contamination , Fatty Liver/etiology , Fatty Liver/pathology , Hemosiderosis/etiology , Hemosiderosis/pathology , Humans , Lead/blood , Lead Poisoning/drug therapy , Lead Poisoning/etiology , Liver/drug effects , Male , Protoporphyrins/blood , Treatment Outcome
16.
São Paulo; s.n; 2018.
Thesis in Portuguese | HomeoIndex (homeopathy) | ID: hom-12081

ABSTRACT

Trabalho realizado a partir de três casos clínicos, em que foram abordados pacientes que apresentaram quadro de sepse de foco abdominal ou pulmonar e foram tratados com medicações homeopáticas dentro da unidade de terapia intensiva (UTI). (AU)


Subject(s)
Humans , Male , Female , Intensive Care Units , Homeopathy , Abdominal Pain/therapy , Asthma/therapy , Shock, Septic/therapy , Pyrogenium/therapeutic use , Kali Carbonicum
17.
Pediatrics ; 115(3): e338-43, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15741360

ABSTRACT

OBJECTIVES: The use of complementary and alternative medicine (CAM) has grown substantially in North America and has drawn the attention of conventional-medicine practitioners. Conventional-medicine practitioners have expressed concern about the potential for unregulated CAM therapies to cause harm, the sometimes-uncertain cost-benefit ratios associated with these therapies, and the possibility that some CAM providers might advise against established conventional therapies, such as vaccination. These concerns are heightened with respect to the pediatric use of CAM products. To address this issue, we conducted a systematic audit of pediatric and adolescent case files at a large, college-based, Canadian naturopathic teaching clinic. We specifically sought to describe the demographic characteristics, reasons for presentation, use of CAM products, and vaccinations status of children presenting for naturopathic assessment. We also determined factors associated with the use of CAM products and vaccination status. METHODS: We identified all charts for children (<18 years of age) who presented to the Robert Schad Naturopathic Clinic, the teaching clinic of the Canadian College of Naturopathic Medicine, between February 1 and May 31, 2002. Data were abstracted directly from the standardized patient intake forms and from clinical notes recorded during the patient's initial visit to the clinic. The following data were obtained: age, gender, chief presenting complaints reported by parents, CAM product use at presentation, vaccination status, and reactions to vaccination. We conducted logistic regression analyses to identify factors associated with both CAM product use and vaccination status. RESULTS: A total of 482 charts were identified. The mean age of patients was 6.5 years (95% confidence interval [CI]: 1.6-11.4 years). The ratio of female subjects to male subjects was 1.09:1 (248:227). The most common reasons for presentation were skin disorders (23%), gastrointestinal complaints (17%), and psychiatric/behavioral disorders (15%). Thirty-five percent of children were using CAM products at presentation (21.2% when both vitamins and minerals were excluded). Vitamins were the most commonly used products (34.6%), followed by herbal remedies (14.9%), oil blends/fats (7.2%), minerals (5.6%), probiotics (4.5%), and homeopathic remedies (3.7%). Of charts with vaccination information, 8.9% indicated that children had not been vaccinated; possible vaccine-associated adverse events were reported for 27% of those who had been vaccinated. Partial or unvaccinated status was associated with younger age, attending the Canadian College of Naturopathic Medicine for advice regarding vaccination, and greater use of CAM products. CAM product use was associated with unvaccinated or partially vaccinated status (odds ratio [OR]: 2.86; 95% CI: 1.46-5.63), presenting with poor energy or fatigue (OR: 3.36; 95% CI: 1.00-11.26), or presenting with throat or sinus infections (OR: 4.06; 95% CI: 1.23-13.04). CONCLUSIONS: Children present for naturopathic assessment for diverse reasons, are high-level consumers of CAM products, and have lower rates of vaccination than population averages. The conventional-medicine community should work with naturopaths to address public health concerns in this population.


Subject(s)
Naturopathy/statistics & numerical data , Abdominal Pain/therapy , Adolescent , Attention Deficit Disorder with Hyperactivity/therapy , Canada , Child , Child, Preschool , Complementary Therapies/statistics & numerical data , Exanthema/therapy , Female , Humans , Infant , Infant, Newborn , Male , Vaccination/statistics & numerical data
18.
Z Gastroenterol ; 40(5): 299-303, 2002 May.
Article in German | MEDLINE | ID: mdl-12016565

ABSTRACT

The occurrence of an opioid addiction within an opioid treatment of pain or diarrhoea in inflammatory bowel disease is rarely reported. We report on a 36-year-old male with a 14 years lasting left sided chronic ulcerative colitis who developed after the initiation of a therapy with tincture of opium because of abdominal pain and diarrhoea an opioid addiction with the consumption of opium and later buprenorphin. Additionally to the diagnostics and therapy of the ulcerative colitis a detoxication was carried out. The diarrhoea slightly increased during the buprenorphin withdrawal. Diarrhoea refractory to other treatment should be treated by loperamid because of its lacking effects on the central nervous system. In chronic abdominal or musculoskeletal pain in inflammatory bowel disease opioids can be used if no surgical or other medical pain relief is possible. A consequent control of the therapeutic and side effects of the opioid therapy is necessary, especially of an abuse of opioid medication. The published case reports of a therapeutic induction of opioid addiction demonstrate that psychiatric comorbidity is an essential or even necessary risk factor. A checklist with seven criteria of opioid addiction during opioid therapy is presented.


Subject(s)
Abdominal Pain/drug therapy , Buprenorphine/administration & dosage , Colitis, Ulcerative/drug therapy , Diarrhea/drug therapy , Opioid-Related Disorders/etiology , Opium/administration & dosage , Abdominal Pain/etiology , Adult , Buprenorphine/adverse effects , Combined Modality Therapy , Diarrhea/etiology , Dose-Response Relationship, Drug , Humans , Male , Opioid-Related Disorders/rehabilitation , Opium/adverse effects , Self Medication , Substance Withdrawal Syndrome/rehabilitation , Substance Withdrawal Syndrome/therapy
19.
Med J Aust ; 178(2): 69-71, 2003 Jan 20.
Article in English | MEDLINE | ID: mdl-12526725

ABSTRACT

OBJECTIVE: To investigate possible routes for human infection by the dog hookworm (Ancylostoma caninum). DESIGN, SETTING AND PARTICIPANT: Relatively small numbers of infective larvae were administered orally and percutaneously to an informed healthy volunteer (J K L) under medical supervision, at intervals between May 1998 and May 1999. MAIN OUTCOME MEASURES: Symptoms; weekly blood eosinophil counts; faecal microscopy. RESULTS: A marked blood eosinophilia followed a single oral exposure to 100 infective larvae, while faecal examination remained negative. Eosinophil counts then declined gradually, although a rapid, spontaneous rise several months later, at the beginning of spring, possibly indicated reactivation of dormant larvae. Blood eosinophil numbers did not rise significantly after percutaneous infection with 200 larvae. A subsequent, smaller, oral inoculum of 20 larvae provoked an eosinophil response similar to that of the first experiment. CONCLUSIONS: Our findings suggest that, following ingestion, some infective larvae of A. caninum develop directly into adult worms in the human gut (as they do in dogs). While the percutaneous route might be the most common means of human exposure to canine hookworm larvae, leading generally to subclinical infection, oral infection may be more likely to provoke symptomatic eosinophilic enteritis.


Subject(s)
Ancylostoma/pathogenicity , Ancylostomiasis/parasitology , Abdominal Pain/etiology , Administration, Cutaneous , Administration, Oral , Adult , Ancylostomiasis/physiopathology , Animals , Autoexperimentation , Dogs , Eosinophilia/etiology , Erythema/etiology , Exudates and Transudates/parasitology , Feces/parasitology , Humans , Larva/pathogenicity , Male , Pruritus/etiology
SELECTION OF CITATIONS
SEARCH DETAIL